8-K/AThe WireRoutine
Shareholder Vote
Filed Sep 22, 2022 · 3y ago · Accession 0001628280-22-025322
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 1662579
- Form type
- 8-K/A
- Filing date
- Sep 22, 2022
- Report date
- Jun 22, 2022
- Document
- cccc-20220622.htm
- Size
- 170 KB